16714-095 : Levalbuterol Inhalation Solution .63 mg/3ml Respiratory (Inhalation) Solution
NDC: | 16714-095 |
Labeler: | Northstar Rxllc |
Product Type: | Human Prescription Drug |
Drug Name: | Levalbuterol Inhalation Solution |
Dosage Form: | Respiratory (Inhalation) Solution |
Application #: | ANDA207820 |
Rev. Date: |
NDC Package Codes:
- 16714-095-25: 5 POUCH IN 1 CARTON (16714‑095‑25) > 5 VIAL, SINGLE‑DOSE IN 1 POUCH > 3 ML IN 1 VIAL, SINGLE‑DOSE
Active Ingredients:
- Levalbuterol Hydrochloride
Dosage Strength:
- .63 mg/3mL
Pharmaceutical Classes:
- Adrenergic beta2-Agonists [MoA]
- beta2-Adrenergic Agonist [EPC]
Related Products:
Based on records with the same trade name.- 16714-094 Levalbuterol Inhalation Solution .31 mg/3ml Respiratory (Inhalation) Solution by Northstar Rxllc
- 16714-096 Levalbuterol Inhalation Solution 1.25 mg/3ml Respiratory (Inhalation) Solution by Northstar Rxllc
- 47335-743 Levalbuterol Inhalation Solution .31 mg/3ml Respiratory (Inhalation) Solution by Sun Pharmaceutical Industries, Inc.
- 47335-746 Levalbuterol Inhalation Solution .63 mg/3ml Respiratory (Inhalation) Solution by Sun Pharmaceutical Industries, Inc.
- 47335-753 Levalbuterol Inhalation Solution 1.25 mg/3ml Respiratory (Inhalation) Solution by Sun Pharmaceutical Industries, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 16714-094Next: 16714-096 >
Related Discussions:
Xopenex (Brand of Levalbuterol)
XOPENEX (pronounced zō-pen-eks) is a fast-acting medicine that is used to treat the narrowing of airways (bronc...
XOPENEX (pronounced zō-pen-eks) is a fast-acting medicine that is used to treat the narrowing of airways (bronc...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.